|
Volumn 9, Issue 3, 2012, Pages 231-235
|
Conference overview: Cancer Immunotherapy and Immunomonitoring (CITIM): Moving forward
|
Author keywords
Cancer; Immunomonitoring; Immunotherapy; Tumor immunology
|
Indexed keywords
ARGINASE 1;
CYCLOPHOSPHAMIDE;
DENDRITIC CELL VACCINE;
INDUCIBLE NITRIC OXIDE SYNTHASE;
INTERLEUKIN 10;
INTERLEUKIN 13;
INTERLEUKIN 8;
IPILIMUMAB;
PROSTAGLANDIN E2;
SIPULEUCEL T;
TRANSFORMING GROWTH FACTOR BETA;
ADVANCED CANCER;
ANTIGEN RECOGNITION;
ARTICLE;
BREAST CANCER;
CANCER CELL;
CANCER IMMUNOTHERAPY;
CANCER PATIENT;
CASTRATION RESISTANT PROSTATE CANCER;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CELL GROWTH;
COLON CANCER;
DENDRITIC CELL;
EPITHELIAL MESENCHYMAL TRANSITION;
HUMAN;
HUNGARY;
IMMUNOREGULATION;
IMMUNOSUPPRESSIVE TREATMENT;
LOW DRUG DOSE;
MACROPHAGE;
MELANOMA;
METASTASIS;
MONOCYTE;
MUTATION;
MYELOID DENDRITIC CELL;
NATURAL KILLER CELL;
NONHUMAN;
PRIORITY JOURNAL;
REGULATORY T LYMPHOCYTE;
T LYMPHOCYTE;
T LYMPHOCYTE ACTIVATION;
TUMOR MICROENVIRONMENT;
VISCUM ALBUM;
ANIMALS;
CONGRESSES AS TOPIC;
EUROPE, EASTERN;
HUMANS;
IMMUNOLOGIC SURVEILLANCE;
IMMUNOTHERAPY;
MONITORING, PHYSIOLOGIC;
NEOPLASMS;
|
EID: 84865336817
PISSN: 1547691X
EISSN: None
Source Type: Journal
DOI: 10.3109/1547691X.2012.686930 Document Type: Article |
Times cited : (2)
|
References (0)
|